Biosyntia
H├╕rsholm
About Biosyntia
Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology. By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds by fermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We partner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow. Biosyntia is located at the Novo Nordisk Foundation (NNF) Center for Biosustainability in Hørsholm, 25 kilometers north of Copenhagen.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $18.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2022)
- Website: biosyntia.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Clinical Trials, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/biosyntia-73900 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.